Literature DB >> 23079999

Limited gene expression variation in human embryonic stem cell and induced pluripotent stem cell-derived endothelial cells.

Mark P White1, Abdul J Rufaihah, Lei Liu, Yohannes T Ghebremariam, Kathryn N Ivey, John P Cooke, Deepak Srivastava.   

Abstract

Recent evidence suggests human embryonic stem cell (hESC) and induced pluripotent stem (iPS) cell lines have differences in their epigenetic marks and transcriptomes, yet the impact of these differences on subsequent terminally differentiated cells is less well understood. Comparison of purified, homogeneous populations of somatic cells derived from multiple independent human iPS and ES lines will be required to address this critical question. Here, we report a differentiation protocol based on embryonic development that consistently yields large numbers of endothelial cells (ECs) derived from multiple hESCs or iPS cells. Mesoderm differentiation of embryoid bodies was maximized, and defined growth factors were used to generate KDR(+) EC progenitors. Magnetic purification of a KDR(+) progenitor subpopulation resulted in an expanding, homogeneous pool of ECs that expressed EC markers and had functional properties of ECs. Comparison of the transcriptomes revealed limited gene expression variability between multiple lines of human iPS-derived ECs or between lines of ES- and iPS-derived ECs. These results demonstrate a method to generate large numbers of pure human EC progenitors and differentiated ECs from pluripotent stem cells and suggest individual lineages derived from human iPS cells may have significantly less variance than their pluripotent founders.
Copyright © 2012 AlphaMed Press.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23079999      PMCID: PMC3528812          DOI: 10.1002/stem.1267

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  32 in total

1.  Derivation of endothelial cells from human embryonic stem cells by directed differentiation: analysis of microRNA and angiogenesis in vitro and in vivo.

Authors:  Nicole M Kane; Marco Meloni; Helen L Spencer; Margaret A Craig; Raimund Strehl; Graeme Milligan; Miles D Houslay; Joanne C Mountford; Costanza Emanueli; Andrew H Baker
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-04-29       Impact factor: 8.311

Review 2.  Endothelial cell plasticity: how to become and remain a lymphatic endothelial cell.

Authors:  Guillermo Oliver; R Sathish Srinivasan
Journal:  Development       Date:  2010-02       Impact factor: 6.868

3.  VEGF induces differentiation of functional endothelium from human embryonic stem cells: implications for tissue engineering.

Authors:  Marilyn B Nourse; Daniel E Halpin; Marta Scatena; Derek J Mortisen; Nathaniel L Tulloch; Kip D Hauch; Beverly Torok-Storb; Buddy D Ratner; Lil Pabon; Charles E Murry
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-10-29       Impact factor: 8.311

Review 4.  Stem cell therapy for vascular regeneration: adult, embryonic, and induced pluripotent stem cells.

Authors:  Nicholas J Leeper; Arwen L Hunter; John P Cooke
Journal:  Circulation       Date:  2010-08-03       Impact factor: 29.690

5.  Convergence of Notch and beta-catenin signaling induces arterial fate in vascular progenitors.

Authors:  Kohei Yamamizu; Taichi Matsunaga; Hideki Uosaki; Hiroyuki Fukushima; Shiori Katayama; Mina Hiraoka-Kanie; Kohnosuke Mitani; Jun K Yamashita
Journal:  J Cell Biol       Date:  2010-04-19       Impact factor: 10.539

6.  Induced pluripotent stem cells and embryonic stem cells are distinguished by gene expression signatures.

Authors:  Mark H Chin; Mike J Mason; Wei Xie; Stefano Volinia; Mike Singer; Cory Peterson; Gayane Ambartsumyan; Otaren Aimiuwu; Laura Richter; Jin Zhang; Ivan Khvorostov; Vanessa Ott; Michael Grunstein; Neta Lavon; Nissim Benvenisty; Carlo M Croce; Amander T Clark; Tim Baxter; April D Pyle; Mike A Teitell; Matteo Pelegrini; Kathrin Plath; William E Lowry
Journal:  Cell Stem Cell       Date:  2009-07-02       Impact factor: 24.633

7.  Transcriptional signature and memory retention of human-induced pluripotent stem cells.

Authors:  Maria C N Marchetto; Gene W Yeo; Osamu Kainohana; Martin Marsala; Fred H Gage; Alysson R Muotri
Journal:  PLoS One       Date:  2009-09-18       Impact factor: 3.240

8.  Enhanced generation of induced pluripotent stem cells from a subpopulation of human fibroblasts.

Authors:  James A Byrne; Ha Nam Nguyen; Renee A Reijo Pera
Journal:  PLoS One       Date:  2009-09-23       Impact factor: 3.240

9.  G(i)-coupled GPCR signaling controls the formation and organization of human pluripotent colonies.

Authors:  Kenta Nakamura; Nathan Salomonis; Kiichiro Tomoda; Shinya Yamanaka; Bruce R Conklin
Journal:  PLoS One       Date:  2009-11-10       Impact factor: 3.240

10.  Expansion and maintenance of human embryonic stem cell-derived endothelial cells by TGFbeta inhibition is Id1 dependent.

Authors:  Daylon James; Hyung-song Nam; Marco Seandel; Daniel Nolan; Tyler Janovitz; Mark Tomishima; Lorenz Studer; Gabsang Lee; David Lyden; Robert Benezra; Nikica Zaninovic; Zev Rosenwaks; Sina Y Rabbany; Shahin Rafii
Journal:  Nat Biotechnol       Date:  2010-01-17       Impact factor: 54.908

View more
  59 in total

Review 1.  Stem cell-based therapies to promote angiogenesis in ischemic cardiovascular disease.

Authors:  Luqia Hou; Joseph J Kim; Y Joseph Woo; Ngan F Huang
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-12-18       Impact factor: 4.733

2.  Effects of cellular origin on differentiation of human induced pluripotent stem cell-derived endothelial cells.

Authors:  Shijun Hu; Ming-Tao Zhao; Fereshteh Jahanbani; Ning-Yi Shao; Won Hee Lee; Haodong Chen; Michael P Snyder; Joseph C Wu
Journal:  JCI Insight       Date:  2016-06-02

3.  Myocardial Infarction-Associated SNP at 6p24 Interferes With MEF2 Binding and Associates With PHACTR1 Expression Levels in Human Coronary Arteries.

Authors:  Mélissa Beaudoin; Rajat M Gupta; Hong-Hee Won; Ken Sin Lo; Ron Do; Christopher A Henderson; Claire Lavoie-St-Amour; Simon Langlois; Daniel Rivas; Stephanie Lehoux; Sekar Kathiresan; Jean-Claude Tardif; Kiran Musunuru; Guillaume Lettre
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-04-02       Impact factor: 8.311

Review 4.  Generation of Human Pluripotent Stem Cell-derived Endothelial Cells and Their Therapeutic Utility.

Authors:  Shin-Jeong Lee; Kyung Hee Kim; Young-Sup Yoon
Journal:  Curr Cardiol Rep       Date:  2018-05-05       Impact factor: 2.931

Review 5.  Application of human induced pluripotent stem cells to model fibrodysplasia ossificans progressiva.

Authors:  Emilie Barruet; Edward C Hsiao
Journal:  Bone       Date:  2017-07-14       Impact factor: 4.398

6.  Self-organized vascular networks from human pluripotent stem cells in a synthetic matrix.

Authors:  Sravanti Kusuma; Yu-I Shen; Donny Hanjaya-Putra; Prashant Mali; Linzhao Cheng; Sharon Gerecht
Journal:  Proc Natl Acad Sci U S A       Date:  2013-07-15       Impact factor: 11.205

Review 7.  Induced Pluripotent Stem Cell-Derived Endothelial Cells: Overview, Current Advances, Applications, and Future Directions.

Authors:  Sae Jang; Alexandra Collin de l'Hortet; Alejandro Soto-Gutierrez
Journal:  Am J Pathol       Date:  2019-01-14       Impact factor: 4.307

8.  Aligned-Braided Nanofibrillar Scaffold with Endothelial Cells Enhances Arteriogenesis.

Authors:  Karina H Nakayama; Guosong Hong; Jerry C Lee; Jay Patel; Bryan Edwards; Tatiana S Zaitseva; Michael V Paukshto; Hongjie Dai; John P Cooke; Y Joseph Woo; Ngan F Huang
Journal:  ACS Nano       Date:  2015-06-17       Impact factor: 15.881

9.  Human disease modeling reveals integrated transcriptional and epigenetic mechanisms of NOTCH1 haploinsufficiency.

Authors:  Christina V Theodoris; Molong Li; Mark P White; Lei Liu; Daniel He; Katherine S Pollard; Benoit G Bruneau; Deepak Srivastava
Journal:  Cell       Date:  2015-03-12       Impact factor: 41.582

Review 10.  Heart regeneration with engineered myocardial tissue.

Authors:  Kareen L K Coulombe; Vivek K Bajpai; Stelios T Andreadis; Charles E Murry
Journal:  Annu Rev Biomed Eng       Date:  2014-04-24       Impact factor: 9.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.